Swedish hospital begins routine omega-3/6 supplementation for preterm infants to cut ROP risk

Umeå University Hospital has begun routine omega-3 and omega-6 supplementation for infants born before 28 weeks, aiming to halve the incidence of retinopathy of prematurity (ROP), a leading cause of childhood blindness. The first treated infant, Kabiel Solomon Syom, was born at 26 weeks. This marks a clinical protocol change based on prior evidence, though long-term efficacy and safety data remain limited.